Genmab A/S (GNMSF)
338.00
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
Genmab Price to Book Value : 3.388 for Aug. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 3.388 |
| August 27, 2026 | 3.388 |
| August 26, 2026 | 3.377 |
| August 25, 2026 | 3.377 |
| August 24, 2026 | 3.284 |
| August 21, 2026 | 3.377 |
| August 20, 2026 | 3.357 |
| August 19, 2026 | 3.207 |
| August 18, 2026 | 3.207 |
| August 17, 2026 | 3.207 |
| August 14, 2026 | 3.113 |
| August 13, 2026 | 3.113 |
| August 12, 2026 | 3.122 |
| August 11, 2026 | 3.122 |
| August 10, 2026 | 3.122 |
| August 07, 2026 | 3.122 |
| August 06, 2026 | 2.956 |
| August 05, 2026 | 2.906 |
| August 04, 2026 | 2.904 |
| August 03, 2026 | 2.826 |
| July 31, 2026 | 2.898 |
| July 30, 2026 | 2.898 |
| July 29, 2026 | 2.898 |
| July 28, 2026 | 2.898 |
| July 27, 2026 | 2.866 |
| Date | Value |
|---|---|
| July 24, 2026 | 2.751 |
| July 23, 2026 | 2.751 |
| July 22, 2026 | 2.751 |
| July 21, 2026 | 2.751 |
| July 20, 2026 | 2.751 |
| July 17, 2026 | 2.826 |
| July 16, 2026 | 2.865 |
| July 15, 2026 | 2.865 |
| July 14, 2026 | 2.865 |
| July 13, 2026 | 2.865 |
| July 10, 2026 | 2.764 |
| July 09, 2026 | 2.842 |
| July 08, 2026 | 2.894 |
| July 07, 2026 | 2.828 |
| July 06, 2026 | 2.828 |
| July 02, 2026 | 2.756 |
| July 01, 2026 | 2.756 |
| June 30, 2026 | 2.756 |
| June 29, 2026 | 2.830 |
| June 26, 2026 | 2.830 |
| June 25, 2026 | 2.830 |
| June 24, 2026 | 2.781 |
| June 23, 2026 | 2.781 |
| June 22, 2026 | 2.701 |
| June 18, 2026 | 2.693 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ascendis Pharma A/S | 9.913 |
| Zealand Pharma A/S | 1.250 |
| Bavarian Nordic A/S | 1.232 |
| Evaxion AS | 2.634 |
| ACADIA Pharmaceuticals, Inc. | 3.835 |
Price to Book Value Related Metrics
| PE Ratio | 26.70 |
| PS Ratio | 5.214 |
| Price to Free Cash Flow | 24.18 |
| Price | 338.00 |
| Earnings Yield | 3.75% |
| Market Cap | 20.18B |
| Operating PE Ratio | 16.15 |
| Normalized PE Ratio | 21.89 |